Summary
When the federal government launched the Oncology Care Model, the goal was to improve the quality of care for Medicare patients receiving chemotherapy while keeping a lid on spending. The voluntary program offered clinics financial incentives to hit specific quality and cost targets. Now, researchers have discovered that the cost-saving habits clinics developed during the program stuck around well after it officially ended. For a full 18 months following the conclusion of the model, participating practices successfully sustained their payment reductions.
During this post-program period, clinics reduced the total cost of a patient care episode by an average of $955. The bulk of these savings was driven by a $559 reduction in Medicare Part B payments, which typically cover outpatient medical services. Interestingly, the researchers found that these specific savings came mostly from spending less on non-chemotherapy drugs.
The study does note some limitations based on how it looked back at past Medicare fee-for-service claims. Because the program was voluntary, the results might reflect a natural selection bias, meaning the clinics that opted in may have already been better equipped to manage costs. However, the data clearly showed that the most dramatic savings came from practices that adopted "two-sided risk." In this setup, clinics could earn bonuses for saving money but also faced financial penalties if they exceeded their budgets. These practices successfully lowered costs across multiple parts of the Medicare system.
Why it matters.
Finding ways to control the skyrocketing costs of cancer care is a major priority for the healthcare industry. This research proves that temporary payment models can create permanent changes in how clinics operate and prescribe medications. By maintaining their efficient practices, the participating clinics generated an impressive $328 million in continued savings for the Medicare system after the original model ended.
These sustained savings had a massive impact on the bottom line for the Centers for Medicare and Medicaid Services. The lingering financial benefits effectively cut the estimated losses of running the original program in half, reducing them from $639 million down to $311 million. Ultimately, this suggests that offering doctors the right mix of financial risks and rewards can permanently rewire healthcare delivery for the better.
The story in numbers.
- Average reduction in total episode payments
- -$955
- Total overall payment reductions post-OCM
- $328 million
- Average payment reduction by practices adopting two-sided risk
- $3,379
Follow the evidence.
This AI-assisted summary is a starting point. Read the original reporting for its methods, scope, and limitations.